InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-9.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Dunsire Deborah, Director. Insider active across 4 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 12 filings have been recorded. History available since 20 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
5,740 shares0Common StockSEC:0000950170-25-074662:0
5,345 shares0Common StockSEC:0000950170-24-075491:0
4,000 sharesCommon StockSEC:0000950170-24-068759:0
3,860 shares0Common StockSEC:0001209191-23-035687:0
8,000 shares0Common StockSEC:0001209191-22-050550:0
3,300 shares0Common StockSEC:0001209191-22-039561:0
14,629 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000073
14,629 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000073:0
2,145 shares0Common stockSEC:0001209191-21-043545
2,145 shares0Common stockSEC:0001209191-21-043545:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000041:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000041
12 of 12 declarations
About Dunsire Deborah
Deborah Dunsire is a board member at Alexion Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. She brings her expertise in biopharmaceuticals to guide strategic decisions and ensure the growth of the companies.
